Where AI becomes real.
OUR COMPANY MISSION IS TO DEVELOP AI TOOLS TO ASSIST HEALTHCARE PROFESSIONALS IN THE DETECTION OF CRITICAL HEALTH ISSUES.
Diagnos is a leader in artificial intelligence and healthcare technical services including algorithm development, data analysis, and image processing ever since 2001.
Screening services aimed at preventing vision loss and other detrimental consequences of chronic disease. Supporting an active research and development program which encompasses: Software development, image processing, algorithm development, data mining / artificial intelligence.
Our technology has assisted the Government of one of the largest provinces in Mexico to preserve people’s health and save millions of dollars.
Every day I see our team in Montreal working tirelessly to develop our AI platform. Every day we can see its positive impact on patients and healthcare partners around the world. Helping them to detect illness in someone’s eyes gives me great pride, and the ability to prevent blindness brings me hope and joy. Delivering intelligence and efficiency with technology to better care is truly a dream of an awesome job.
I want to improve global health through a digital transformation in the health industry by focusing on Early Detection of critical health issues through the use of Artificial Intelligence. My goal is to use technology to enable doctors and nurses in primary care facilities to monitor closely the effect of diabetes, and other diseases, to ensure no one loses their vison. The power of this approach is based on combining practicable knowledge and technology to prevent the un-detected.
The CARA platform is a tool designed for importing, processing, and storing of original and enhanced image through computerized networks. It can add value to any organization engaged in the monitoring of eye diseases such as diabetic retinopathy.
We are constantly working on developing new products using AI such as tools to help predict cardiovascular artery diseases. These new tools will be available for marketing and sale upon receipt of all applicable regulatory authorizations.